Correlation Between Iovance Biotherapeutics and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Iovance Biotherapeutics and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Apogee Therapeutics,.
Diversification Opportunities for Iovance Biotherapeutics and Apogee Therapeutics,
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Iovance and Apogee is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Apogee Therapeutics,
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Apogee Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 1.27 times less risky than Apogee Therapeutics,. The stock trades about -0.28 of its potential returns per unit of risk. The Apogee Therapeutics, Common is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest 4,732 in Apogee Therapeutics, Common on October 25, 2024 and sell it today you would lose (840.00) from holding Apogee Therapeutics, Common or give up 17.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Apogee Therapeutics, |
Iovance Biotherapeutics and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Apogee Therapeutics,
The main advantage of trading using opposite Iovance Biotherapeutics and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Apogee Therapeutics, vs. Regeneron Pharmaceuticals | Apogee Therapeutics, vs. The Mosaic | Apogee Therapeutics, vs. Inhibrx | Apogee Therapeutics, vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |